跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
DALVOCANS POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 50MG/ VIAL - HSA Drug Approval Details
Approvals
/
HSA
/
DALVOCANS POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 50MG/ VIAL
Approved
THERAPEUTIC
DALVOCANS POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 50MG/ VIAL
MEFAR ILAC SANAYII A.S. (TURKEY)ELPEN PHARMACEUTICAL CO., INC (GREECE)
🇸🇬 Health Sciences Authority
Approval Date
Sep 28, 2018
Approval ID
d0de49614ef1d0c2
Company
MEFAR ILAC SANAYII A.S. (TURKEY)ELPEN PHARMACEUTICAL CO., INC (GREECE)
Type
Therapeutic
Approval Details
Approval Id
d0de49614ef1d0c2
Drug Name
DALVOCANS POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 50MG/ VIAL
Product Name
DALVOCANS POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 50MG/ VIAL
Approval Number
SIN15551P
Approval Date
2018-09-28
Registrant
NOVEM HEALTHCARE PTE LTD
Licence Holder
NOVEM PHARMA PRIVATE LIMITED
Drug Type
Therapeutic
Forensic Classification
Prescription Only
Dosage Form
INJECTION, POWDER, FOR SOLUTION
Route Of Administration
INTRAVENOUS
Atc Code
J02AX04
Atc Item Name
caspofungin
Pharma Manufacturer Name
LOTUS INTERNATIONAL PTE. LTD.
Active Ingredients
Caspofungin Acetate 55.52mg/ vial eqv. Caspofungin
50mg/ vial
CASPOFUNGIN ACETATE 55.52 MG/VIAL EQV. CASPOFUNGIN
50 MG/VIAL
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Sep 28, 2018
Approval ID
d0de49614ef1d0c2
Type
Therapeutic
Back to HSA Approvals